Prevalence of DNA Mismatch Repair Deficiency in Endometrial Cancer Using Immunohistochemistry

被引:0
|
作者
Mehdizadeh, Behnoush [1 ]
Gharib, Masoumeh [2 ]
Jafarian, Amir Hossein [3 ]
Afzalaghaee, Monavvar [4 ]
Shandiz, Fateme Homaee [5 ]
Irajpour, Amirhosein [6 ]
机构
[1] Birjand Univ Med Sci, Dept Surg & Clin Pathol, Fac Med, Birjand, Iran
[2] Mashhad Univ Med Sci, Dept Pathol, Fac Med, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Canc Mol Pathol Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Dept Community Med, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Dept RadioOncol, Canc Res Ctr, Fac Med, Mashhad, Razavi Khorasan, Iran
[6] Shahid Beheshti Univ Med Sci, Dept Surg, Tehran, Iran
关键词
Lynch Syndrome; Endometrial Cancer; Immunohistochemistry; NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; RISK; ASSOCIATION; EXPRESSION; MUTATIONS;
D O I
10.5812/ijcm-119065
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endometrial cancer (EC) is known as the most common malignancy of the female reproductive system, suggested to be associated with hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome (LS). Objectives: Therefore, the aim of the present study was to screen for LS in patients with EC using immunohistochemistry (IHC). Methods: In this retrospective cross-sectional study, the patients with EC, referred to Qaem Hospital, Mashhad, Iran, from 2015 2019, were enrolled. Paraffin-embedded tissue blocks were then examined via IHC for the expression of four mismatch repair (MMR) proteins, includingMLH1, MSH2, MSH6, andPMS2. Thedemographicandtumor-related datawerealso extractedfrommedical records and pathology reports. The data were consequently analyzed at the significance level of P < 0.05. Results: A total number of 100 patients with EC were evaluated using IHC, and 12 (12%) cases were found suspected. As well, no significant relationship was observed between LS and age, tumor site, tumor histology, tumor size, tumor grade, tumor-infiltrating lymphocytes (TILs), and a family/personal history of malignancies. Conclusions: The prevalence of LS based on the IHC expression of the MMR proteins (MLH1, MSH2, MSH6, and PMS2) was 12% in the patients with EC. There was also no significant relationship between the cases suspected and the demographic and tumor-related data.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications
    Doghri, Raoudha
    Houcine, Yoldez
    Boujelbene, Nadia
    Driss, Maha
    Charfi, Lamia
    Abbes, Imene
    Mrad, Karima
    Sellami, Rini
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (09) : 678 - 682
  • [2] DNA mismatch repair proteins immunohistochemistry in young women with endometrial cancer
    Sotiropoulou, M.
    Markoulis, P.
    Minaidou, E.
    Pavlou, V.
    Voulgaris, Z.
    VIRCHOWS ARCHIV, 2011, 459 : S249 - S249
  • [3] The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
    Favier, Amelia
    Varinot, Justine
    Uzan, Catherine
    Duval, Alex
    Brocheriou, Isabelle
    Canlorbe, Geoffroy
    CANCERS, 2022, 14 (15)
  • [4] Immunohistochemistry to determine mismatch repair-deficiency in endometrial cancer: the appropriate standard
    Powell, M. A.
    ANNALS OF ONCOLOGY, 2017, 28 (01) : 9 - 10
  • [5] DNA Mismatch Repair Deficiency in Endometrial Carcinoma
    Karamurzin, Yevgeniy
    Rutgers, Joanne K. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2009, 28 (03) : 239 - 255
  • [6] The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening
    Oka, Suguru
    Urakami, Shinji
    Hagiwara, Kiichi
    Hayashida, Michikata
    Sakaguchi, Kazushige
    Miura, Yuji
    Inoshita, Naoko
    Arai, Masami
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2023, 21 (01)
  • [7] The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening
    Suguru Oka
    Shinji Urakami
    Kiichi Hagiwara
    Michikata Hayashida
    Kazushige Sakaguchi
    Yuji Miura
    Naoko Inoshita
    Masami Arai
    Hereditary Cancer in Clinical Practice, 21
  • [8] DNA MISMATCH REPAIR DEFICIENCY IN YOUNG PATIENTS WITH SPORADIC ENDOMETRIAL CANCER
    Chu, M. M. Y.
    Liu, S. S.
    Ip, P.
    Tam, K. F.
    Cheung, A. N. Y.
    Ngan, H. Y. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [9] Targeting mismatch repair deficiency in endometrial cancer
    Begum, R.
    Martin, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S76 - S77
  • [10] Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
    Post, Cathalijne C. B.
    Stelloo, Ellen
    Smit, Vincent T. H. B. M.
    Ruano, Dina
    Tops, Carli M.
    Vermij, Lisa
    Rutten, Tessa A.
    Jurgenliemk-Schulz, Ina M.
    Lutgens, Ludy C. H. W.
    Jobsen, Jan J.
    Nout, Remi A.
    Crosbie, Emma J.
    Powell, Melanie E.
    Mileshkin, Linda
    Leary, Alexandra
    Bessette, Paul
    Putter, Hein
    de Boer, Stephanie M.
    Horeweg, Nanda
    Nielsen, Maartje
    van Wezel, Tom
    Bosse, Tjalling
    Creutzberg, Carien L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (09): : 1212 - 1220